Vocal Cord Paralysis Market Report 2024

This Vocal Cord Paralysis market report covers industry characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The vocal cord paralysis market size has grown steadily in recent years. It will grow from $2.65 billion in 2023 to $2.77 billion in 2024 at a compound annual growth rate (CAGR) of 4.7%. The growth during the historic period can be attributed to several factors, including a rise in neurological disorders, greater awareness of vocal cord paralysis, a higher prevalence of head and neck surgeries, an increase in trauma and injury cases, and the expansion of the elderly population.

The vocal cord paralysis market size is expected to see strong growth in the next few years. It will grow to $3.38 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth during the forecast period can be attributed to several factors, including the rising prevalence of chronic diseases, increased awareness of voice disorders, a higher incidence of respiratory infections, more cases of head and neck cancers, and a growing number of patients undergoing thyroid surgery. Major trends for the forecast period include advancements in technology, the use of telemedicine for vocal health, the integration of artificial intelligence, development of diagnostic tools, and the adoption of surgical robotics.

The rising prevalence of neurological disorders is projected to drive growth in the vocal cord paralysis market. Neurological disorders, which encompass conditions affecting the brain, spinal cord, and peripheral nerves, are increasingly prevalent due to various factors such as genetic predisposition, infections, trauma, toxins, autoimmune responses, and degenerative processes. Neurological conditions, including stroke, multiple sclerosis, Parkinson’s disease, and other neuromuscular disorders, often result in complications such as vocal cord paralysis due to their adverse effects on nerve function and muscle control. As the global incidence of these neurological disorders increases, the number of patients with vocal cord paralysis is also anticipated to rise. For instance, in April 2022, according to data from the European Brain Council, over 600 neurological diseases and nearly 300 psychiatric conditions impact millions of individuals worldwide, with epilepsy affecting approximately 65 million people. In Europe alone, there are currently 10.5 million individuals with dementia, with projections indicating an increase to 18.7 million by 2050. This high prevalence of neurological disorders is expected to significantly contribute to the growth of the vocal cord paralysis market.

Major players in the vocal cord paralysis market are concentrating on advancing technologies to improve diagnosis, treatment, and management of the condition. This focus includes the development of AI-assisted wearable devices designed to enhance patient outcomes and overall quality of life. AI-assisted wearable devices integrate artificial intelligence to expand their functional capabilities, offering innovative solutions for vocal cord paralysis. For instance, in March 2024, UCLA (University of California, Los Angeles), a prominent public research university based in the US, introduced an adhesive neck patch specifically designed to aid individuals with vocal cord dysfunction. This innovative device, measuring just over 1 square inch, adheres to the skin on the throat and is aimed at restoring voice function. The patch comprises two main components, a self-powered sensing element that detects and converts muscle movement signals into high-fidelity electrical signals, and an actuation component that processes these electrical signals into speech signals through a machine-learning algorithm.

In November 2021, Coloplast A/S, a healthcare company headquartered in Denmark, completed the acquisition of Atos Medical for an undisclosed amount. This strategic acquisition is part of Coloplast's broader initiative to expand its product portfolio and enhance its position within the global market for innovative healthcare solutions. Atos Medical AB, based in Sweden, is a specialist in medical devices and solutions designed for individuals with voice and swallowing disorders.

Major companies operating in the vocal cord paralysis market are Aetna Inc., Sanofi SA, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Smith & Nephew plc, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Smiths Medical, Teleflex Incorporated, Karl Storz SE & Co. KG, Cook Medical, PENTAX Medical, Merz Therapeutics, NuVasive Inc., Atos Medical AB, Advanced Bionics AG, Cytophil Inc., Topeka ENT, Intersect ENT Inc.

North America was the largest region in the vocal cord paralysis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vocal cord paralysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vocal cord paralysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Vocal cord paralysis is a condition characterized by impaired movement of one or both vocal cords (vocal folds). This impairment can affect a person's ability to speak, breathe, and swallow, depending on the severity of the condition and which vocal cords are involved.

The primary types of vocal cord paralysis are bilateral and unilateral. Bilateral vocal cord paralysis occurs when both vocal cords are paralyzed, whereas unilateral vocal cord paralysis affects only one vocal cord. Treatment options include surgery and voice therapy, and these are utilized by various end users, such as hospitals, ambulatory surgical centers, specialty clinics, and others.

The vocal cord paralysis market research report is one of a series of new reports that provides vocal cord paralysis market statistics, including vocal cord paralysis industry global market size, regional shares, competitors with a vocal cord paralysis market share, detailed vocal cord paralysis market segments, market trends and opportunities, and any further data you may need to thrive in the vocal cord paralysis industry. This vocal cord paralysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vocal cord paralysis market includes revenues earned by entities by providing diagnosis and assessment, speech therapy, and counseling services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.